Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
JNJ 303
Cat. No.:
OB0425LY-246
Appearance:
Solid
Purity:
99.6%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
JNJ 303 is a potent delayed rectifier Kv blocker that potent blocks IKs.
Synonyms:
878489-28-2; Rel-2-(4-Chlorophenoxy)-2-methyl-N-((1S,2R)-5-(methylsulfonamido)adamantan-2-yl)propanamide; 2-(4-Chlorophenoxy)-N-[(1S,3R)-5-(methanesulfonamido)-2-adamantyl]-2-methylpropanamide; 2-(4-Chlorophenoxy)-2-methyl-N-[5-[(methylsulfonyl)amino]tricyclo[3.3.1.13,7]dec-2-yl]-propanamide
CAS No.:
878489-28-2
Compound CID:
11575823
Formula:
C21H29ClN2O4S
Formula Weight:
440.98
Specification
Target:
Potassium channel
Pathway:
Membrane transporter/Ion channel
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
JNJ 303 can be used in diabetes, obesity and central nervous system research.
